{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:56:03Z","timestamp":1793908563732,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M762242"],"award-info":[{"award-number":["2024M762242"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clineuro.2025.109110","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:19:11Z","timestamp":1754954351000},"page":"109110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical characteristics and prognostic analysis of glutamic acid decarboxylase 65-associated neurological syndromes: A retrospective study from Southwest China"],"prefix":"10.1016","volume":"257","author":[{"given":"Tong","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jierui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.clineuro.2025.109110_bib1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199005313222202","article-title":"Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome","volume":"322","author":"Solimena","year":"1990","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109110_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jnnp.71.1.100","article-title":"Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases","volume":"71","author":"Meinck","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.clineuro.2025.109110_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1471-4159.1993.tb03165.x","article-title":"Regulation of gamma-aminobutyric acid synthesis in the brain","volume":"60","author":"Martin","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clineuro.2025.109110_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.750869","article-title":"Heterogeneous GAD65 expression in subtypes of GABAergic neurons across layers of the cerebral cortex and hippocampus","volume":"15","author":"Kajita","year":"2021","journal-title":"Front Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109110_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"issue":"Pt 10","key":"10.1016\/j.clineuro.2025.109110_bib6","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.clineuro.2025.109110_bib7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy","volume":"71","author":"Ari\u00f1o","year":"2014","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109110_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","article-title":"Clinical spectrum of high-titre GAD65 antibodies","volume":"92","author":"Budhram","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109110_bib9","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000696","article-title":"Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment","volume":"7","author":"Mu\u00f1oz-Lopetegi","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2025.109110_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2019.04.007","article-title":"The neurological syndromes associated with glutamic acid decarboxylase antibodies","volume":"101","author":"Baizabal-Carvallo","year":"2019","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109110_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70237","article-title":"Clinical features of glutamic acid Decarboxylase-65 neurological autoimmunity: a case series from China","volume":"31","author":"Qiu","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109110_bib12","first-page":"e904","article-title":"GAD65 Antibody-Associated neurologic disease presenting with hemiparkinsonism at onset","volume":"11","author":"Patel","year":"2021","journal-title":"Neurol. Clin. Pr."},{"issue":"9","key":"10.1016\/j.clineuro.2025.109110_bib13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/81.9.1207","article-title":"Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction","volume":"81","author":"Pittock","year":"2006","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.clineuro.2025.109110_bib14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified rankin scale: implications for stroke clinical trials: a literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109110_bib15","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109110_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mus.20653","article-title":"Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome","volume":"34","author":"Espay","year":"2006","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clineuro.2025.109110_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.clineuro.2025.109110_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2025.109110_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41582-020-0359-x","article-title":"GAD antibodies in neurological disorders - insights and challenges","volume":"16","author":"Graus","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109110_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaclp.2022.07.005","article-title":"Psychiatric symptoms in Stiff-Person syndrome: a systematic review and a report of two cases","volume":"64","author":"Nasri","year":"2023","journal-title":"J. Acad. Consult Liaison Psychiatry"},{"issue":"4-5","key":"10.1016\/j.clineuro.2025.109110_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/09602010701202238","article-title":"Neuropsychological and psychiatric profiles in acute encephalitis in adults","volume":"17","author":"Pewter","year":"2007","journal-title":"Neuropsychol. Rehabil."},{"key":"10.1016\/j.clineuro.2025.109110_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2022.10.011","article-title":"Differential effects of anxiety on long-term outcomes of acute coronary syndrome and stroke according to their disease severities","volume":"321","author":"Kim","year":"2023","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.clineuro.2025.109110_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00415-025-12926-3","article-title":"GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice","volume":"272","author":"Brown","year":"2025","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2025.109110_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/1744666X.2013.845527","article-title":"Immunology of stiff person syndrome and other GAD-associated neurological disorders","volume":"9","author":"Alexopoulos","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109110_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","article-title":"Consensus paper: neuroimmune mechanisms of cerebellar ataxias","volume":"15","author":"Mitoma","year":"2016","journal-title":"Cerebellum"},{"issue":"6","key":"10.1016\/j.clineuro.2025.109110_bib26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archneur.61.6.902","article-title":"Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity","volume":"61","author":"Rakocevic","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2025.109110_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fneur.2018.00579","article-title":"Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and Anti-epileptic drugs","volume":"9","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"Front Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109110_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1570159X16666180917105033","article-title":"Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges","volume":"17","author":"Mitoma","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.clineuro.2025.109110_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2016.10.016","article-title":"Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis","volume":"65","author":"Hansen","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.clineuro.2025.109110_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","article-title":"Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy","volume":"80","author":"Daif","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.clineuro.2025.109110_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","article-title":"Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies","volume":"30","author":"Malter","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.clineuro.2025.109110_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.12.010","article-title":"Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies","volume":"129","author":"Carre\u00f1o","year":"2017","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.clineuro.2025.109110_bib33","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1111\/epi.18086","article-title":"Outcomes of surgical resection and vagus nerve stimulation in patients with medically refractory epilepsy and glutamic acid decarboxylase 65 antibody positivity","volume":"65","author":"Zhao-Fleming","year":"2024","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.clineuro.2025.109110_bib34","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/01.wnl.0000276946.08412.ef","article-title":"Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy","volume":"69","author":"Bien","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109110_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"issue":"Pt 5","key":"10.1016\/j.clineuro.2025.109110_bib36","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.clineuro.2025.109110_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","article-title":"Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients","volume":"58","author":"Honnorat","year":"2001","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2025.109110_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2169\/internalmedicine.55.5156","article-title":"Prevalence of autoantibodies and the efficacy of immunotherapy for autoimmune cerebellar ataxia","volume":"55","author":"Nanri","year":"2016","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109110_bib39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12311-013-0534-3","article-title":"Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies","volume":"13","author":"Planche","year":"2014","journal-title":"Cerebellum"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725003932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725003932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:35:06Z","timestamp":1772804106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725003932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"alternative-id":["S0303846725003932"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109110","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and prognostic analysis of glutamic acid decarboxylase 65-associated neurological syndromes: A retrospective study from Southwest China","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109110"}}